Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Tolerability of Adjunctive Linezolid for the Treatment of Tuberculous Meningitis

NCT04021121 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04021121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04021121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Tolerability of Adjunctive Linezolid for the Treatment of Tuberculous Meningitis
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
May 5, 2021
Completion date
December 4, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, meningeal